If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Rezvoglar ™ (insulin glargine-aglr) injection
3 mL (100 units/mL)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Can Rezvoglar™ (insulin glargine-aglr) be used in animals?
Lilly recommends that owners contact their veterinarian for information on the use of insulin in their pets.
Use of Insulin in Animals
Rezvoglar™ (insulin glargine-aglr) 100 units/mL is not approved for use in animals.1 While insulins are available for use in animals, Eli Lilly and Company recommends that owners contact their veterinarian for information regarding the use of insulins in their pets.
Enclosed Prescribing Information
1Rezvoglar [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.
Date of Last Review: February 04, 2022